Avivagen Inc
Avivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in the United States, Mex… Read more
Avivagen Inc (VIVXF) - Total Liabilities
Latest total liabilities as of July 2023: $9.54 Million USD
Based on the latest financial reports, Avivagen Inc (VIVXF) has total liabilities worth $9.54 Million USD as of July 2023.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Avivagen Inc - Total Liabilities Trend (2006–2022)
This chart illustrates how Avivagen Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Avivagen Inc Competitors by Total Liabilities
The table below lists competitors of Avivagen Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Forte Group Holdings Inc.
PINK:FGHFF
|
USA | $10.61 Million |
|
Pilot Gold Inc
STU:PGW
|
Germany | €6.78 Million |
|
Future Generation Australia Ltd
AU:FGX
|
Australia | AU$38.17 Million |
|
CHINA CITIC BK -H-
MU:D7C
|
Germany | €8.43 Trillion |
|
METALS X (FG5.SG)
STU:FG5
|
Germany | €58.70 Million |
Liability Composition Analysis (2006–2022)
This chart breaks down Avivagen Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.03 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.03 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 35.00 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Avivagen Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Avivagen Inc (2006–2022)
The table below shows the annual total liabilities of Avivagen Inc from 2006 to 2022.
| Year | Total Liabilities | Change |
|---|---|---|
| 2022-10-31 | $7.35 Million | -1.09% |
| 2021-10-31 | $7.43 Million | +7.01% |
| 2020-10-31 | $6.94 Million | +34.99% |
| 2019-10-31 | $5.14 Million | +70.58% |
| 2018-10-31 | $3.02 Million | +79.39% |
| 2017-10-31 | $1.68 Million | -64.95% |
| 2016-10-31 | $4.80 Million | +36.33% |
| 2015-10-31 | $3.52 Million | +7.88% |
| 2014-10-31 | $3.26 Million | -2.13% |
| 2013-10-31 | $3.33 Million | -27.82% |
| 2012-10-31 | $4.62 Million | -1.43% |
| 2011-10-31 | $4.68 Million | +25.64% |
| 2010-10-31 | $3.73 Million | +43.89% |
| 2009-10-31 | $2.59 Million | +47.05% |
| 2008-10-31 | $1.76 Million | +129.11% |
| 2007-10-31 | $768.79K | +230.21% |
| 2006-10-31 | $232.82K | -- |